Abstract The goal of the present work is to give a review of developments achieved experimentally in the field of nuclear data for medically important radioisotopes in the last 3 years. The availability and precision of production related nuclear data is continuously improved mainly experimentally. This review emphasizes a couple of larger fields: the Mo/Tc generator problem and the generator isotopes in general, heavy a-emitters and the rare-earth elements. Other results in the field of medical radioisotope production are also listed.
Introduction
Nuclear data play an important role in the production and the application of medical radioisotopes. Out of the basic nuclear data, the activation cross sections and the related production yields are also requested. These data can be obtained experimentally and/or by using nuclear reaction codes. The significance of the experimental data is twofold: they give direct information for the production and they also contribute to the development of nuclear reaction model codes. During the previous dedicated and satellite investigations, large amount of activation data were measured. In spite of the large experimental databases and the significant progress in the reaction theory, the importance of collection of reliable experimental data has not decreased. New candidate radioisotopes appear for diagnostics and therapy, the radioisotope impurities became more important, new experimental techniques appear to measure low radioactivities, weak performance of nuclear theory was recognized for some type of nuclear reactions and for the metastable states, preparation of recommended databases require re-measurement of mostly used reactions due to contradicting data. Application of high-energy accelerators, usefulness of deuteron induced reactions, broader application of numerous low energy cyclotrons all require further data measurements and improvements.
Nuclear data for medical applications are mainly used in the following fields: production of radioisotopes (medical), dosimetry calculations (staff, patients), radiotherapy planning, diagnostics and economy (planning of the production, distribution, treatment, etc.).
The necessary nuclear data can be divided into two larger groups: i.e. structure and decay data, which are mainly interesting for fundamental research but also used for medical physics, and the excitation functions and production yields, which are rather application related data. The sources of stored nuclear data are manifold, if one is interested in the source publications, then turns to such publication databases as the WoS (Web of Science) [1] . If more precise compiled data are necessary then the source is the EXFOR (Experimental Nuclear Reaction Data) [2] database, and evaluated data can be found in the newest version of the ENDF (Evaluated Nuclear Data Library) [3] libraries.
Experimental data
The most important medically related radioisotopes and their basic nuclear data are listed in different literature sources [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . These sources might not contain the new emerging radioisotopes under investigation, which are referred in the following sections. If really reliable production related data are needed, one can search in the experimental databases. The experimental groups perform their measurements by using: activation method, sometimes followed by chemical separation, on solid or gas targets. Single target, rotating wheel or stacked targets are used. The activity is measured by using c, X-ray and aspectrometry or mass spectrometry.
The most frequent goals of these studies are: new isotopes for medical, industrial and other purposes; new production routes of important isotopes; side reactions and impurities; clarification of disagreements between previous measurements.
According to our experiences, the published results are not always free of problems. These problems can be summarized as follows:
• The available poor technology in some laboratories (beam intensity, beam energy measurement, target preparation, chemical separation).
• Missing basic knowledge on data measurement, data evaluation, definitions, etc.
• Too optimistic uncertainties.
• The reports are not detailed enough for data corrections and for production of covariance matrices.
Some groups, especially those participating in coordinated research programs try to address these problems in the recent publications. In addition, people responsible for database inputs pay more attention to the above problems when evaluating a new work. Out of medical applications, the published results can also be used for basic nuclear physics research, development of theoretical models, improvement of computer codes based on these models, industrial applications, energy related and safety/security related applications. According to the last IAEA recommendations [4] particular data improvements are needed at the following areas:
• Monitor reactions (induced by light ions in the used energy ranges). • Therapeutic electron and X-ray emitters ( 131 Cs, 178 Ta).
Out of these recommendations also the 111 In, 201 Tl, 119 Sb, 97 Ru therapeutic electron and X-ray emitters require further data improvements. The recently emerged theranostic approach in nuclear medicine, which consists of performing imaging of the bio-distribution and therapy in the same time, by using the same isotope or different isotopes of the same element or isotopes of two elements with similar chemical behavior, opened a new field in nuclear data experiments and renewed the interest for some radionuclides. In the last 3-4 years, developments have been achieved in the field of experimental production data in the following four areas. Heavy a-emitters a-emitter isotopes have a promising future in the field of targeted radio-therapy. The emitted a-particles are relatively heavy projectiles, having different energies with short range in human tissues. That's why they can easily induce the medically required double-strand DNA break in the tumor cells without damaging the surrounding healthy cells. New results have been published for the a-particle and proton induced production of 211 225 Ac on a thorium target are shown. Two groups measured this excitation function in overlapping energy ranges. The agreement in the medium energy region is not so good.
Rare earth elements
As there are a lot of emerging medical radioisotopes between the rare earth elements, most of the new results have been published in this field. Out of the rare earth radioisotopes, also new data for other important radio-products (side products) were determined. New experimental data were published for proton induced production of Hf, Lu and Ta radioisotopes on natural Hf target [33] , proton induced production of Ho radioisotopes on Dy target [34] , Zr, Y, Sr, Rb radioisotope production on natural yttrium by proton irradiation [35] , measurement of the excitation functions of Pm, Nd, Pr and Ce radioisotopes on natural Nd target with deuteron activation [36] , production of Yb and Tm radioisotopes on thulium target by proton activation [37] . As an example, the new production cross section of the medically interesting therapeutic 161 Ho radio-lanthanide, which is an Augerelectron emitter, is presented in Fig. 3 . This cross section has not been measured before, that's why the results were compared with the output of the different theoretical nuclear reaction model codes (such as TALYS, ALICE and EMPIRE [38] [39] [40] ). These codes give good trend but different and incorrect quantitative estimation for the cross section.
Generators
Radioisotope generators are very important in the everyday medical practice, because they make possible the access to short-lived radioisotopes without the presence of a medical accelerator in the vicinity of the hospital. The most important generator/daughter pair is the 99 Mo/ 99m Tc, which was discussed in detail in a previous section. As an example for this part, the new results on 62 Zn for 62 Cu generator is shown in Fig. 4 . It contains both proton [32, [41] [42] [43] and deuteron [44] induced routes. From the results presented in Fig. 4 , only the for proton irradiation and the data of Simeckova [44] for deuteron irradiation are new (from the last 3 years), the others are presented for comparison. The figure shows that the newest 62 Zn data for proton irradiation support the previous results and also confirm that the proton induced route is preferable than the deuteron one for its production. New results have also been published for 178 W production (generator for 178 Ta) [45, 46] , for 44 Ti production (generator for 44 [36] .
Other new results
New results on other medically interesting nuclear data have also been published in the last 3 years:
• Production cross section of 110m,110g,111g,114m In on natural cadmium with a-particle irradiation and many side reactions producing In, Cd and Sn radioisotopes [49] (PET, b -, electron emitter respectively).
• Production cross section of 186g Re with deuteron [50] and proton [45] irradiation on natural tungsten target and side products (therapy).
• Production cross section of 203, 201 Pb and 201 Tl on natural thallium with proton irradiation and many side products [51] (SPECT).
• Production parameters of 105 Rh by proton irradiation of natural palladium [52] (therapy).
• Production cross section of 167 Tm and many side thulium and ytterbium products by proton irradiation of natural thulium [37] (therapy).
• Production cross section of 66, 67, 68 Ga by proton irradiation of 68 Zn and a-particle irradiation of natural copper [53] (SPECT, PET).
• Production cross section of 90,95g Nb and 88 Y with side products by proton irradiation of natural zirconium [54] (PET).
• Production cross section of 11 C, 15 O and 13 N isotopes by proton irradiation of the corresponding target elements [55] (PET).
• Production of 67 Cu by deuteron irradiation of natural zinc [56] (therapy).
• Production cross Sect. 123 Cs by proton irradiation of 124 Xe [57] (SPECT).
• Production cross section of 123 Xe by a-particle [58] and proton irradiation of 120 Te and 124 Xe targets [57] respectively (SPECT).
• Production cross section of 51 Cr by proton irradiation of natural chromium, 56 161 Ho radioisotope by proton bombardment of natural dysprosium and comparison with the results of the different nuclear reaction model codes 55 Mn [61] and 59 Co [62] as well as by deuteron irradiation of natural iron [63, 64] , natural vanadium [65] , 55 Mn [66] , natural chromium [67] and natural nickel [68, 69] , production of 52 Mn by proton irradiation of natural chromium [70] (SPECT, PET).
• Production cross section of 90 Nb by proton induced reactions of natural zirconium [54] 
induced reaction on natural molybdenum (PET).
• Production cross sections of 147, 149 Gd by proton and deuteron induced reactions on natural europium [71] (SPECT).
Conclusions
The status of the nuclear reaction databases for medical applications has been significantly improved. Further developments are important in both the reaction and decay fields. It requires new, dedicated experiments, reliable (proved) experimental technique, new evaluation technique and proper reporting of the experimental data.
Some isotopes are emerging, especially in the field of theranostic applications. It requires further measurements for these new isotopes and also re-measurements of isotopes having renewed interest. The results provided by the nuclear reaction model codes are not always satisfactory, that's why further and closer co-operation is necessary between the code developers and experimental groups.
The huge amount of new data on medical radioisotopes confirms the large potential of experimental groups behind the work. The IAEA NDS is only one organization trying to promote and improve the co-operation in the nuclear data, especially the medical nuclear data field. Independent groups also provided important contribution to the experimental nuclear data for the medical radioisotopes (see in the section ''Other new results''). 
